Skip to main content

CONSECUENCIAS PARA LA HOMEOSTASIS CELULAR DEL DESEQUILIBRIO EN LA REPARACION DEL DNA

PID2019-104195GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multivalent calixarene-based liposomes as platforms for gene and drug delivery

  • Lebrón, José Antonio
  • López-López, Manuel
  • García-Calderón, Clara B.
  • Rosado, Iván V.
  • Balestra, Fernando R.
  • Huertas Sánchez, Pablo
  • Rodik, Roman V.
  • Kalchenko, Vitaly I.
  • Bernal, Eva
  • Moyá, María Luisa
  • López-Cornejo, Pilar
  • Ostos, Francisco José
The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC12)4, were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC12)4/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC12)4/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug., This work was financed by the Consejería de Conocimiento, Innovación y Universidades de la Junta de Andalucía (FQM-206, FQM-274, and PY20-01234), the VI Plan Propio Universidad de Sevilla (PP2019/00000748), RTI2018-100692-B-100; P18-RT-1271; PI18-0005-2018; VI-PP AY.SUPLEM- 2019; RYC-2015-18670, The R+D+I grant PID2019-104195G from the Spanish Ministry of Science and Innovation-Agencia Estatal de Investigación/10.13039/501100011033 (P.H.) and the European Union (Feder Funds). The authors thank the University of Seville for the grant VPPI-US. J.A.L. also thanks the Fundación ONCE funded by the Fondo Social Europeo.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Emerging Role of RNA Modifications in DNA Double-Strand Break Repair

  • Jimeno, Sonia
  • Balestra, Fernando R.
  • Huertas Sánchez, Pablo
The correct repair of DNA double-strand breaks is essential for maintaining the stability of the genome, thus ensuring the survival and fitness of any living organism. Indeed, the repair of these lesions is a complicated affair, in which several pathways compete for the DNA ends in a complex balance. Thus, the fine-tuning of the DNA double-strand break repair pathway choice relies on the different regulatory layers that respond to environmental cues. Among those different tiers of regulation, RNA modifications have just emerged as a promising field., This work was funded by the R+D+I grant PID2019-104195G from the Spanish Ministry of Science and Innovation-Agencia Estatal de Investigación/10.13039/50110001103. FB is funded by the University of Seville through a postdoctoral contract of the V PPIT-US. CABIMER is supported by the Regional Government of Andalucia (Junta de Andalucía).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair

  • Jimeno, Sonia
  • Prados-Carvajal, Rosario
  • Fernández-Ávila, María Jesús
  • Silva, Sonia
  • Silvestris, Domenico Alessandro
  • Endara-Coll, Martin
  • Rodríguez-Real, Guillermo
  • Domingo-Prim, Judit
  • Mejías-Navarro, Fernando
  • Romero-Franco, Amador
  • Jimeno-González, Silvia
  • Barroso, Sonia
  • Cesarini, Valeriana
  • Aguilera, Andrés
  • Gallo, Ángela
  • Visa, Neus
  • Huertas Sánchez, Pablo
The maintenance of genomic stability requires the coordination of multiple cellular tasks upon the appearance of DNA lesions. RNA editing, the post-transcriptional sequence alteration of RNA, has a profound effect on cell homeostasis, but its implication in the response to DNA damage was not previously explored. Here we show that, in response to DNA breaks, an overall change of the Adenosine-to-Inosine RNA editing is observed, a phenomenon we call the RNA Editing DAmage Response (REDAR). REDAR relies on the checkpoint kinase ATR and the recombination factor CtIP. Moreover, depletion of the RNA editing enzyme ADAR2 renders cells hypersensitive to genotoxic agents, increases genomic instability and hampers homologous recombination by impairing DNA resection. Such a role of ADAR2 in DNA repair goes beyond the recoding of specific transcripts, but depends on ADAR2 editing DNA:RNA hybrids to ease their dissolution., This work was funded by an R + D + I grant from the Agencia Estatal de Investigación PID2019-104195GB-I00/ AEI/10.13039/501100011033 (P.H.), R + D + I grants from the Spanish Ministry of Economy and Competitiveness (SAF2016-74855-P to P.H. and BFU2016-75058-P to A.A.), the European Research Council (ERC2014 AdG669898 TARLOOP to A.A.), the Associazione Italiana Ricerca sul Cancro-AIRC (AIRC IG 22080 to A.G.), The Swedish Research Council (grants 2015-04553 to N.V.), The Swedish Cancer Society (grant CAN 2016/460 to N.V.) and the European Union (FEDER). AR is, and FM-N and RP-C were, funded with FPU fellowships from the Spanish Ministry of Education and S.S. by a Juan de la Cierva contract from the Spanish Ministry of Economy and Competitiveness. J.D.P. and M.E-C. were supported by the Department of Molecular Biosciences, The Wenner-Gren Institute at Stockholm University. J.D-P. and R.P-C. were recipients of short-term EMBO fellowships (STF- 7513-2018 and STF-7764-2018). The mutational results shown here are in whole or part based upon the data generated by the TCGA Research Network: https://www.cancer.gov/tcga. All the bioinformatic analyses were performed using custom scripts that were run on the High performance computing cluster provided by the Centro Informático Cienti ́fico de Andalucía (CICA). CABIMER is supported by the regional government of Andalucia (Junta de Andalucía).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Effect of Atypical Nucleic Acids Structures in DNA Double Strand Break Repair: A Tale of R-loops and G-Quadruplexes

  • Camarillo, Rosa
  • Jimeno, Sonia
  • Huertas Sánchez, Pablo
The fine tuning of the DNA double strand break repair pathway choice relies on different regulatory layers that respond to environmental and local cues. Among them, the presence of non-canonical nucleic acids structures seems to create challenges for the repair of nearby DNA double strand breaks. In this review, we focus on the recently published effects of G-quadruplexes and R-loops on DNA end resection and homologous recombination. Finally, we hypothesized a connection between those two atypical DNA structures in inhibiting the DNA end resection step of HR., This work was funded by the R + D + I grant PID 2019-104195G from the Spanish Ministry of Science and Innovation-Agencia Estatal de Investigación/10.13039/501100011033. RC-D is funded by an FPI fellowships from the Spanish Ministry of Science. CABIMER is supported by the regional government of Andalucia (Junta de Andalucía).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PLK1 regulates CtIP and DNA2 interplay in long-range DNA end resection

  • Ceppi, Ilaria
  • Cannavo, Elda
  • Bret, Hélène
  • Camarillo, Rosa
  • Vivalda, Francesca
  • Thakur, Roshan Singh
  • Romero-Franco, Amador
  • Sartori, Alessandro A.
  • Huertas Sánchez, Pablo
  • Guérois, Raphaël
  • Cejka, Petr
DNA double-strand break (DSB) repair is initiated by DNA end resection. CtIP acts in short-range resection to stimulate MRE11-RAD50-NBS1 (MRN) to endonucleolytically cleave 5'-terminated DNA to bypass protein blocks. CtIP also promotes the DNA2 helicase-nuclease to accelerate long-range resection downstream from MRN. Here, using AlphaFold2, we identified CtIP-F728E-Y736E as a separation-of-function mutant that is still proficient in conjunction with MRN but is not able to stimulate ssDNA degradation by DNA2. Accordingly, CtIP-F728E-Y736E impairs physical interaction with DNA2. Cellular assays revealed that CtIP-F728E-Y736E cells exhibit reduced DSB-dependent chromatin-bound RPA, impaired long-range resection, and increased sensitivity to DSB-inducing drugs. Previously, CtIP was shown to be targeted by PLK1 to inhibit long-range resection, yet the underlying mechanism was unclear. We show that the DNA2-interacting region in CtIP includes the PLK1 target site at S723. The integrity of S723 in CtIP is necessary for the stimulation of DNA2, and phosphorylation of CtIP by PLK1 in vitro is consequently inhibitory, explaining why PLK1 restricts long-range resection. Our data support a model in which CDK-dependent phosphorylation of CtIP activates resection by MRN in S phase, and PLK1-mediated phosphorylation of CtIP disrupts CtIP stimulation of DNA2 to attenuate long-range resection later at G2/M., This work was supported by European ResearchCouncil grants (ERC) 681630 and 101018257 and Swiss National Science Foundation grants 31003A_175444 and 310030_205199 to P.C.; Research, Development, and Innovation (R+D+I) grant PID2019-104195G from the Spanish Ministry of Science and Innovation- Agencia Estatal de Investigación 10.13039/ 501100011033 to P.H.; grant ANR-21-CE44-0009-01 from French government to R.G.; and Swiss National Science Foundation grant 310030_208143 to A.A.S. A.R.-F. is funded with a Formación del Profesorado Universitario (FPU) fellowship from the SpanishMinistry of Education, and R.C. is funded by a predoctoral fellowship from the Spanish Ministry of Science. Centro Andaluz de Biología Molecular y Medicina Regenerativa is supported by the regional government of Andalucia (Junta de Andalucía)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Centriolar subdistal appendages promote double‐strand break repair through homologous recombination

  • Rodríguez‐Real, Guillermo
  • Domínguez-Calvo, Andrés
  • Prados‐Carvajal, Rosario
  • Bayona-Feliu, Aleix
  • Gomes‐Pereira, Sonia
  • Balestra, Fernando R.
  • Huertas Sánchez, Pablo
. This work was funded by the R+D+I grant US‐1255532 Proyectos I+D+i FEDER Andalucía 2014‐2020 from the Junta de Andalucía, the grant P18‐RT‐1204 from the Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía and the grant PID2019‐104195G from the Spanish Ministry of Science and Innovation‐Agencia Estatal de Investigación/https://doi.org/10.13039/501100011033. CABIMER is supported by the regional government of Andalucía (Junta de Andalucía). ADC is funded with FPU fellowships from the Spanish Ministry of Education and RPC is funded with an AECC postdoctoral fellowship. We also want to thank Paul Guichard and Virginie Hamel (University of Geneva, Department of Cell Biology, Sciences III, Geneva, Switzerland) for their support developing the U‐ExM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

EXO1 and DNA2-mediated ssDNA gap expansion is essential for ATR activation and to maintain viability in BRCA1-deficient cells

  • García-Rodríguez, Néstor
  • Domínguez-García, Iria
  • Domínguez-Pérez, M. Carmen
  • Huertas Sánchez, Pablo
DNA replication faces challenges from DNA lesions originated from endogenous or exogenous sources of stress, leading to the accumulation of single-stranded DNA (ssDNA) that triggers the activation of the ATR checkpoint response. To complete genome replication in the presence of damaged DNA, cells employ DNA damage tolerance mechanisms that operate not only at stalled replication forks but also at ssDNA gaps originated by repriming of DNA synthesis downstream of lesions. Here, we demonstrate that human cells accumulate post-replicative ssDNA gaps following replicative stress induction. These gaps, initiated by PrimPol repriming and expanded by the long-range resection factors EXO1 and DNA2, constitute the principal origin of the ssDNA signal responsible for ATR activation upon replication stress, in contrast to stalled forks. Strikingly, the loss of EXO1 or DNA2 results in synthetic lethality when combined with BRCA1 deficiency, but not BRCA2. This phenomenon aligns with the observation that BRCA1 alone contributes to the expansion of ssDNA gaps. Remarkably, BRCA1-deficient cells become addicted to the overexpression of EXO1, DNA2 or BLM. This dependence on long-range resection unveils a new vulnerability of BRCA1-mutant tumors, shedding light on potential therapeutic targets for these cancers., Marie Skolodowska-Curie Fellowship from the European Union’s Horizon 2020 Programme [MSCA-IF-2017-794054]; EMERGIA 2021 program from the Andalusian Regional Government-Junta de Andalucía [EMC21_00057 to N.G.-R.]; work in the laboratory of PH was funded by a grant from the Spanish Ministry of Science and Innovation [PID2019-104195G]. Funding for open access charge: Universidad de Sevilla., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Radiotherapy resistance driven by Asparagine endopeptidase through ATR pathway modulation in breast cancer

  • Morillo-Huesca, Macarena
  • López-Cepero, Ignacio G.
  • Conesa-Bakkali, Ryan
  • Tomé, Mercedes
  • Watts, Colin
  • Huertas, Pablo
  • Moreno-Bueno, Gema
  • Durán, Raúl V.
  • Martínez-Fábregas, Jonathan
Tumor resistance represents a major challenge in the current oncology landscape. Asparagine endopeptidase (AEP) overexpression correlates with worse prognosis and reduced overall survival in most human solid tumors. However, the underlying mechanisms of the connection between AEP and reduced overall survival in cancer patients remain unclear., Research and publication of this work was funded by the EMERGIA 2021 program (EMERGIA21_00124) from the Consejería de Universidad, Investigación e Innovación, Junta de Andalucía, Spain to J.M-F. J.M-F. was supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie programme (101025429), the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MICINN-AEI, RYC2021-032389), the Consejería de Universidad, Investigación e Innovación under the EMERGIA program (EMC21_00124) Junta de Andalucia, and the VII PPIT of the University of Seville (2023/00000479). RVD and G.M-B were supported by MICINN-AEI and European Regional Development Fund (project PID2021-124251OB-I00 and PID2022-136854OB-I00, respectively). G.M-B was also funded by The Instituto de Salud Carlos III IISCIII, CIBERONC (CB16/12/00295) and ERA PerMed ERA-NET co-funded by the NextGeneration-EU (ISCIII and Fundacion cientifica AECC, AC21_2/00020). PH was supported by R + D + I grant (PID2019-104195G) from the Spanish Ministry of Science and Innovation-Agencia Estatal de Investigación/10.13039/501100011033. CW was supported by a Welcome Trust Programme Grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression

  • Khalife, Manal
  • Jia, Tao
  • Caron, Pierre
  • Shreim, Amani
  • Genoux, Aurelie
  • Cristini, Agnese
  • Pucciarelli, Amelie
  • Leverve, Marie
  • Lepeltier, Nina
  • García-Rodríguez, Néstor
  • Dalonneau, Fabien
  • Ramachandran, Shaliny
  • Fernandez Martinez, Lara
  • Marcion, Guillaume
  • Lemaitre, Nicolas
  • Brambilla, Elisabeth
  • Garrido, Carmen
  • Hammond, Ester M.
  • Huertas, Pablo
  • Gazzeri, Sylvie
  • Sordet, Olivier
  • Eymin, Beatrice
SRSF2 (serine/arginine-rich splicing factor 2) is a critical regulator of pre-messenger RNA splicing, which also plays noncanonical functions in transcription initiation and elongation. Although elevated levels of SRSF2 are associated with advanced stages of lung adenocarcinoma (LUAD), the mechanisms connecting SRSF2 to lung tumor progression remain unknown. We show that SRSF2 overexpression increases global transcription and replicative stress in LUAD cells, which correlates with the production of DNA damage, notably double-strand breaks (DSBs), likely resulting from conflicts between transcription and replication. Moreover, SRSF2 regulates DNA repair pathways by promoting homologous recombination and inhibiting nonhomologous end joining. Mechanistically, SRSF2 interacts with and enhances MRE11 (meiotic recombination 11) recruitment to chromatin, while downregulating 53BP1 messenger RNA and protein levels. Both events are likely contributing to SRSF2-mediated DNA repair process rerouting. Lastly, we show that SRSF2 and MRE11 expression is commonly elevated in LUAD and predicts poor outcome of patients. Altogether, our results identify a mechanism by which SRSF2 overexpression promotes lung cancer progression through a fine control of both DSB production and repair. Finally, we show that SRSF2 knockdown impairs late repair of ionizing radiation-induced DSBs, suggesting a more global function of SRSF2 in DSB repair by homologous recombination., This work was supported by Institut National de la Santé et de la Recherche Médicale (Inserm), by Centre National de la Recherche Scientifique (CNRS), by Univ. Grenoble Alpes, by the Fondation ARC (PJA 2014-1201788), by the Comités Départementaux Allier, Isère and Savoie de la Ligue Nationale contre le Cancer, by Institut National du Cancer (INCa) [INCa-PLBIO/Canceropole Ile de France (PLBIO-2014-08 to M.K., M.L., and A.P.); (INCA_16730 to P.C.)], by Région Auvergne-Rhône-Alpes (Programme Pack Ambition Recherche 2021), by Association Espoir Isère Contre Le Cancer, and by association GEFLUC Grenoble. T.J. was supported by INCa-PLBIO (INCa-PLBIO#2016-155). A.P. was funded by ERICAN program of Fondation MSDAVENIR (DS-2018-0015) supported by Canceropole CLARA. Work at Pablo Huertas’ lab was funded by the R + D + I grant PID2019-104195G from the Spanish Ministry of Science and Innovation—Agencia Estatal de Investigación/10.13039/501100011033 and N.G.-R. was the recipient of a MSCA-IF-2017 (DNACHECK). CABIMER is supported by the regional government of Andalucia (Junta de Andalucía). O.S. lab is funded by the Inserm, the Institut National du Cancer (INCa) (INCA_16730 and INCA_19472), and the Fondation pour la Recherche Médicale (FRM) [Equipe labelisée FRM (DEQ20170839117)]. A.C. research is funded by Inserm, the Fondation ARC (Dossier n° ARCPJA2023090007177), and the Fondation de France (N° engagement: 00097702, 00113878, and 00119148). L.F.M. is supported by the La Ligue Nationale Contre le Cancer (IP/SC/SK-17250) and the Fondation pour la Recherche Médicale (Dossier n° FDT202404018232)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DNA topoisomerase IIß inhibition blocks DNA end resection and synergizes with PARPi in BRCA1-deficient models

  • Camarillo, Rosa
  • Prados-Carvajal, Rosario
  • Cruz-García, Andrés
  • Rodríguez-Real, Guillermo
  • Herencia-Ropero, Andrea
  • Serra, Violeta
  • Jimeno, Sonia
  • Huertas Sánchez, Pablo
DNA end resection is a critical step that governs how a broken chromosome will be repaired. As such, it is heavily regulated by multiple cellular signals and processes. Alterations in the regulation of DNA end resection have consequences for cell survival upon exposure to cytotoxic agents, including those used during cancer chemotherapy. Here, we identified several small molecules that affect the process of DNA end resection. Among them, we focus on determining the mode of action of merbarone, a DNA topoisomerase II inhibitor. We uncover a role of the topoisomerase IIβ isoform in the full processing of DNA breaks. Moreover, we show that the effect of merbarone is affected by the formation of G4 quadruplexes and that BRCA1-deficient cancer cells are sensitive to merbarone. Strikingly, this sensitivity can be partially suppressed in cell lines expressing hypomorphic versions of BRCA1 lacking exon 11, a hypomorph that has been linked to PARPi-resistance. Using cellular models, we show that PARPi- and merbarone-resistant BRCA1 exon 11 mutant cells, but not wildtype BRCA1 cells, are sensitive to the combination of both drugs. Finally, we show that combination of merbarone and the PARPi olaparib has a mild antitumor effect in a PARPi-resistant PDX model bearing a BRCA1 exon 11 mutation., This work was funded by the R+D+I grants SAF2013-43255-P, SAF2016-74855-P, PID2019-104195G and PID2022-136791NB-I00 funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE to P.H., and grants PID2022-140603NB-I00 funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE and the Ideas Semilla Project IDEAS222767JIME from the Asociación Española Contra el Cáncer (AECC) to S.J and the SINERGIA project SNRGS247052PRAD from AECC to RP-C. RC-D was funded with an FPI fellowship from the Spanish Ministry of Economy and Competitivity. RP-C was funded with an FPU fellowship from the Spanish Ministry of Education and a Postdoctoral Fellowship from the Asociación Española Contra el Cáncer (AECC). AC-G was supported by the Government of Mexico with a fellowship of the CONACYT. CABIMER is supported by the Regional Government of Andalucía (Junta de Andalucía). V.S. received funds from the Instituto de Salud Carlos III (ISCIII), an initiative of the Spanish Ministry of Economy and Innovation partially supported by European Regional Development FEDER Funds (PI20/00892 and CPII19/00033). AH-R received funding from Generalitat de Catalunya (PERIS SLT017/20/000081). P. Huertas and R. Prados-Carvajal disclose non-financial support from AstraZeneca. Additionally, V. Serra reports research grants from AstraZeneca and personal fees and/or nonfinancial support from AstraZeneca and GSK., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Circadian regulation of homologous recombination by cryptochrome1-mediated dampening of DNA end resection

  • Romero-Franco, Amador
  • Checa-Rodríguez, Cintia
  • Jimeno, Sonia
  • Castellano-Pozo, Maikel
  • Aguilera, Paula
  • Miras, Héctor
  • Wals-Zurita, Amadeo
  • Jimeno-González, Silvia
  • López-Contreras, Andrés J.
  • Huertas, Pablo
[Data availability] All relevant data are included in the manuscript.Source data are provided with this paper. ChIP-seq data are deposited at GEO under the accession number GSE261427. All data is available from the authors upon request. Source data are provided with this paper., Genomic stability maintenance requires the repair of DNA breaks in the most accurate fashion. So, an exquisite regulatory network controls the choice between different repair mechanisms to maximize genome integrity. This relies mostly at the level of DNA end resection, the initial steps of the homologous recombination. On the other hand, numerous cellular activities follow a 24 h oscillation known as the circadian cycle. Thus, we explored the regulation of the choice between different DNA break repair pathways along the circadian cycle. Here we show that in human cells DNA resection shows a circadian oscillation, with a peak at early morning followed by a partial and progressive reduction until late afternoon. Such regulation depends on the circadian clock core component CRY1, which modulates the anti-resection activity of CCAR2 to limit CtIP at nightfall. Additionally, such regulation requires DNA-PK-mediated phosphorylation of CRY1. Finally, this circadian regulation impacts cancer progression and response to radiation therapy of specific tumours., This work was funded by the R + D + I grants PID2019-104195G and PID2022-136791NB-I00 funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE, the grant P18-RT-1204 from the Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía and the grant PRYGN246626HUER from the Asociación Española Contra el Cáncer. The mouse work in the ALC laboratory was funded by the R+D+I grant PID2020-119329RB-I00, the SJ lab is funded by the grant PID2022-140603NB-I00, and the SJG lab is funded by the grant PID2022-139253N, all three funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE. MC-P is the recipient of an MSCA-IF-2020 (coDNAres) that covers his salary and part of the reagents. AR-F is funded with a FPU fellowship from the Spanish Ministry of Education and PA was supported by a postdoctoral fellowship from the Junta de Andalucía and the European Social Fund (202099908313486), and by a postdoctoral grant from the Scientific Foundation of the Spanish Association Against Cancer (POSTD234422AGUI). CABIMER is supported by the regional government of Andalucía (Junta de Andalucía). We thank José Carlos Reyes-Rosa for the critical reading of the manuscript. We also want to thank the Microscopy and Genomic Unit of CABIMER for their support in the experiments., Peer reviewed